Fine Foods H1 FY26 turns to net loss of €2.4 million; revenue slips 3.1% to €124.8 million
Reuters2026/09/08 12:08- Fine Foods & Pharmaceuticals NTM posted H1 2026 revenue of €124.8 million, down 3.1% from H1 2025.
- Pharma BU revenue rose 12% to €46.6 million, lifted by the fully operational Brembate site and Sofar consolidation.
- IFRS net result turned to a loss of €2.4 million from a profit a year earlier, hit by a €4 million non-cash impairment.
- Adjusted EBITDA fell to €15.2 million, down from €21.6 million; margin narrowed 4.6 percentage points to 12.2%.
- Net financial position widened to €98 million from €47.9 million at end-2025, reflecting Sofar acquisition spending and capex.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Storage Giant Offers Huge Bonuses Again: Micron Awards Up to 68 Months’ Bonus
Micron Technology has announced record-breaking bonuses for its employees in Taiwan, ranging from 35 to 68 months’ salary, with a minimum cash compensation of 1.7 million New Taiwan dollars. However, the Taoyuan union, representing about two-thirds of Micron’s workers in Taiwan, has refused to accept the offer, insisting that 15% of operating profits be included in the bonus distribution and maintaining the threat of a strike.
Dogecoin ETF Closure Sets October Exit for Bitwise BWOW Holders
Crypto prices
More
